Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels

Oncology Letters
Qiang WangJie Cao

Abstract

Resistance to oxaliplatin (L-OHP) is a major obstacle to successful chemotherapy in colorectal cancer (CRC). In the present study, the ability of gambogic acid (GA) to reverse L-OHP resistance in CRC LoVo cells was investigated. L-OHP-resistant LoVo/L-OHP cells were established by exposing them to increasing concentrations of L-OHP. GA-reversed L-OHP-sensitive LoVo/L-OHP/GA cells were established by exposure to 0.5 µmol/l GA for 2 weeks. A Cell Counting Kit-8 assay was used to assess levels of proliferation. Flow cytometry was applied to detect apoptosis rates. Transwell assays were used to analyse invasion. Inductively coupled plasma mass spectrometry was used to determine intracellular platinum (Pt) content. Western blot analysis was used to reveal the protein levels of Human copper transporter 1 (hCTR1), Copper-transporting p-type adenosine triphosphatases 1 (ATP7A) and Copper-transporting p-type adenosine triphosphatases 2 (ATP7B). LoVo/L-OHP and LoVo/L-OHP/GA cell lines were successfully established, and it was identified that L-OHP inhibited the proliferation of LoVo, LoVo/L-OHP and LoVo/L-OHP/GA cells in a dose-dependent manner. Compared with the parent LoVo cells, the anti-apoptosis and invasion properties of LoVo/L-OHP...Continue Reading

References

Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Seiko IshidaIra Herskowitz
Oct 17, 2007·Annual Review of Pharmacology and Toxicology·Matthew D HallMichael M Gottesman
Nov 22, 2007·Cancer Chemotherapy and Pharmacology·Noriaki KitadaTeruyoshi Yokoyama
Apr 4, 2008·Journal of Ethnopharmacology·Qi QiQinglong Guo
Nov 11, 2008·Cancer Chemotherapy and Pharmacology·Cara A RabikM Eileen Dolan
Jan 15, 2009·The Journal of Biological Chemistry·Karoline LeonhardtDominik Huster
Mar 20, 2009·International Journal of Cancer. Journal International Du Cancer·Eva Martinez-BalibreaAlbert Abad
May 28, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lingegowda S MangalaAnil K Sood
Feb 18, 2010·Molecular Pharmacology·Stephen B HowellMichael J Sailor
Feb 19, 2011·Current Oncology·T Alcindor, N Beauger
Jul 27, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Helen H W ChenWu-Chou Su
Feb 26, 2013·Cell Biochemistry and Biophysics·Jianxia Wang, Zhixiang Yuan
Mar 19, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Na LuQing-Long Guo
Apr 16, 2013·International Journal of Pharmaceutics·Tam T T N NguyenBente Gammelgaard
Aug 12, 2014·Pathology Oncology Research : POR·Yong ZhangJianhua Xu
Oct 23, 2014·Interventional Neurology·Jiaping Xu, Yongjun Cao
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
May 13, 2015·Frontiers in Pharmacology·Saliha Harrach, Giuliano Ciarimboli
Jul 18, 2015·Molecular Cancer Therapeutics·Eva Martinez-BalibreaAlbert Abad
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He

❮ Previous
Next ❯

Citations

Aug 17, 2021·Frontiers in Oncology·Chengxing WangYaoming He

❮ Previous
Next ❯

Methods Mentioned

BETA
light microscopy
flow cytometry

Software Mentioned

Image J
FlowJo
SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis